1. AHRO : Austin Health Research Online

Sagun Parakh

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Sagun Parakh
Full Name
Parakh, Sagun
 
Department
 
ORCID
Loading... 3 0 20 0 false

Publications

Results 21-40 of 53 (Search time: 0.018 seconds).

Publication YearTitleAuthor(s)
21Nov-2021Standard-Dose Osimertinib in EGFR-Mutated Non-Small-Cell Lung Adenocarcinoma With Leptomeningeal Disease.McLean, Luke S; Faisal, Wasek; Parakh, Sagun ; Kao, Steven C; Lewis, Craig R; Chin, Melvin T; Voskoboynik, Mark; Itchins, Malinda J; Jennens, Ross R; Broad, Adam R; Morris, Tessa A; Solomon, Benjamin J
223-Aug-2021Tumor volumes as a predictor of response to the anti-EGFR antibody drug conjugate depatuxizumab mafadotin.Gan, Hui K ; Parakh, Sagun ; Lassman, Andrew B; Seow, Aidan; Lau, Eddie ; Lee, Sze Ting ; Ameratunga, Malaka; Perchyonok, Yuliya ; Cao, Diana; Burvenich, Ingrid J G; O'Keefe, Graeme J; Rigopoulos, Angela; Gomez, Erica; Maag, David; Scott, Andrew M 
231-Jul-2021Response Evaluation and Survival Prediction After PD-1 Immunotherapy in Patients with Non-Small Cell Lung Cancer: Comparison of Assessment Methods.Ayati, Narjess ; Lee, Sze Ting ; Zakavi, S Rasoul; Cheng, Melissa; Lau, W F Eddie; Parakh, Sagun ; Pathmaraj, Kunthi ; Scott, Andrew M 
249-Jun-2021PDCD1 Polymorphisms May Predict Response to Anti-PD-1 Blockade in Patients With Metastatic Melanoma.Parakh, Sagun ; Musafer, Ashan; Paessler, Sabrina; Witkowski, Tom ; Suen, Connie S N Li Wai; Tutuka, Candani S A; Carlino, Matteo S; Menzies, Alexander M; Scolyer, Richard A; Cebon, Jonathan S ; Dobrovic, Alexander ; Long, Georgina V; Klein, Oliver ; Behren, Andreas
25Mar-2021Expression of EGFR and conformational forms of EGFR in malignant pleural mesothelioma and its impact on survival.Chia, Puey Ling ; Parakh, Sagun ; Russell, Prudence; Gan, Hui K ; Asadi, Khashayar ; Gebski, Val; Murone, Carmel ; Walkiewicz, Marzena; Liu, Zhanqi; Thapa, Bibhusal ; Scott, Fiona E; Scott, Andrew M ; John, Thomas 
26Jan-2021Inefficiencies in phase II to phase III transition impeding successful drug development in glioblastoma.Balasubramanian, Adithya ; Gunjur, Ashray ; Hafeez, Umbreen ; Menon, Siddharth; Cher, Lawrence M ; Parakh, Sagun ; Gan, Hui K 
272021Immune Checkpoint Inhibition With Chemoradiotherapy in Stage III Non-small-cell Lung Cancer: A Systematic Review and Meta-analysis of Safety Results.Balasubramanian, Adithya ; Onggo, James; Gunjur, Ashray ; John, Thomas ; Parakh, Sagun 
2827-Nov-2020Response evaluation and survival prediction following PD-1 immunotherapy in patients with non-small-cell lung cancer: comparison of assessment methods.Ayati, Narjess ; Lee, Sze Ting ; Zakavi, Seyed Rasoul; Cheng, Melissa; Lau, Eddie ; Parakh, Sagun ; Pathmaraj, Kunthi ; Scott, Andrew M 
2916-Oct-2020Antibody-Drug Conjugates for Cancer Therapy.Hafeez, Umbreen ; Parakh, Sagun ; Gan, Hui K ; Scott, Andrew M 
302-Oct-2020Targeting and Efficacy of Novel mAb806-Antibody-Drug Conjugates in Malignant Mesothelioma.Chia, Puey Ling ; Parakh, Sagun ; Tsao, Ming-Sound; Pham, Nhu-An; Gan, Hui K ; Cao, Diana; Burvenich, Ingrid J G; Rigopoulos, Angela; Reilly, Edward B; John, Thomas ; Scott, Andrew M 
3110-Jun-2020Impact of Radiotherapy on the Efficacy and Toxicity of anti-PD-1 Inhibitors in Metastatic NSCLC.Samuel, Evangeline; Lie, Gabrielle ; Balasubramanian, Adithya ; Hiong, Alison; So, Yeojeong; Voskoboynik, Mark; Moore, Maggie; Shackleton, Mark; Haydon, Andrew; John, Tom; Mitchell, Paul L R ; Markman, Ben; Briggs, Peter; Parakh, Sagun 
322020Current Development of Monoclonal Antibodies in Cancer Therapy.Parakh, Sagun ; King, Dylan ; Gan, Hui K ; Scott, Andrew M 
332020Sensitization of Cancers Resistant to HER2 Antibodies.Parakh, Sagun ; Gan, Hui K ; Scott, Andrew M 
34Oct-2019Young adults diagnosed with high grade gliomas: Patterns of care, outcomes, and impact on employment.Hafeez, Umbreen ; Menon, Siddarth; Nguyen, Bella; Lum, Caroline; Gaughran, Gregory; Pranavan, Ganesalingham; Cher, Lawrence; Nowak, Anna K; Gan, Hui K ; Parakh, Sagun 
35Aug-2019A pilot study of intrahepatic yttrium-90 microsphere radioembolization in combination with intravenous cisplatin for uveal melanoma liver-only metastases.Arulananda, Surein; Parakh, Sagun ; Palmer, Jodie ; Goodwin, Mark D ; Andrews, Miles C; Cebon, Jonathan S 
36Feb-2019Real-world efficacy and toxicity of combined nivolumab and ipilimumab in patients with metastatic melanoma.Parakh, Sagun ; Randhawa, Manreet; Nguyen, Bella; Warburton, Lydia; Hussain, Mohammad Akhtar; Cebon, Jonathan S ; Millward, Michael; Yip, Desmond; Ali, Sayed
37Jul-2018Molecular imaging of T cell co-regulator factor B7-H3 with 89Zr-DS-5573a.Burvenich, Ingrid J G; Parakh, Sagun ; Lee, Fook-Thean; Guo, Nancy; Liu, Zhanqi; Gan, Hui K ; Rigopoulos, Angela; O'Keefe, Graeme Joseph; Gong, Sylvia Jie; Goh, Yit Wooi; Tochon-Danguy, Henri; Scott, Fiona Elizabeth; Kotsuma, Masakatsu; Hirotani, Kenji; Senaldi, Giorgio; Scott, Andrew M 
388-Mar-2018Receptor Occupancy Imaging Studies in Oncology Drug Development.Burvenich, Ingrid J G; Parakh, Sagun ; Parslow, Adam C; Lee, Sze Ting ; Gan, Hui K ; Scott, Andrew M 
392018Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of IntralesionalBacillus Calmette-Guérinfollowed by Ipilimumab in Patients with Advanced Metastatic Melanoma.Da Gama Duarte, Jessica; Parakh, Sagun ; Andrews, Miles C; Woods, Katherine; Pasam, Anupama; Tutuka, Candani; Ostrouska, Simone; Blackburn, Jonathan M; Behren, Andreas; Cebon, Jonathan S 
402018Delayed Autoimmune Toxicity Occurring Several Months After Cessation of Anti-PD-1 Therapy.Parakh, Sagun ; Cebon, Jonathan S ; Klein, Oliver